Market Place
Sourcing Support
Abdera Therapeutics Names Rachael as Chief Scientific Officer
08 Jul 2025 //
BUSINESSWIRE
Abdera to Present Radiopharmaceutical Updates at AACR Meeting
23 Apr 2025 //
BUSINESSWIRE
Abdera To Present At 43rd J.P. Morgan Healthcare Conference
09 Jan 2025 //
BUSINESSWIRE
Abdera Therapeutics Receives FDA Orphan Drug Designation for ABD-147
05 Sep 2024 //
BUSINESSWIRE
Vistagen Earns Mental Health America’s Platinum Bell Seal for Workplace
27 Jun 2024 //
BUSINESSWIRE
Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147
23 May 2024 //
BUSINESSWIRE
Abdera Therapeutics Expands Management Team and Board of Directors
30 Jan 2024 //
BUSINESSWIRE
Abdera Therapeutics Debuts With $142 Million in Financing to Engineer
20 Apr 2023 //
BUSINESSWIRE
Abdera exits stealth with $142M to develop radiopharmaceuticals
20 Apr 2023 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.